Chicago Partners Investment Group LLC Reduces Position in iShares Biotechnology ETF $IBB

Chicago Partners Investment Group LLC cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 14.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,873 shares of the financial services provider’s stock after selling 1,318 shares during the period. Chicago Partners Investment Group LLC’s holdings in iShares Biotechnology ETF were worth $1,066,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Kanawha Capital Management LLC boosted its stake in shares of iShares Biotechnology ETF by 1.4% during the 2nd quarter. Kanawha Capital Management LLC now owns 8,767 shares of the financial services provider’s stock worth $1,109,000 after purchasing an additional 124 shares during the period. Harbor Asset Planning Inc. purchased a new position in iShares Biotechnology ETF in the 2nd quarter worth about $31,000. Endowment Wealth Management Inc. increased its stake in iShares Biotechnology ETF by 30.4% in the 2nd quarter. Endowment Wealth Management Inc. now owns 4,585 shares of the financial services provider’s stock worth $580,000 after buying an additional 1,070 shares during the period. Johnson Investment Counsel Inc. increased its stake in iShares Biotechnology ETF by 7.8% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 3,924 shares of the financial services provider’s stock worth $496,000 after buying an additional 283 shares during the period. Finally, Trust Co. of Toledo NA OH purchased a new position in iShares Biotechnology ETF in the 2nd quarter worth about $32,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.5%

IBB stock opened at $156.49 on Tuesday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $157.01. The firm’s 50-day moving average is $143.43 and its 200 day moving average is $131.77.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.